TNFSF10 and neoplasm: One promising approach involves the genetic modification of platelets to express surface-bound tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a cytokine known to induce apoptosis specifically in tumor cells, which has shown efficacy in inhibiting tumor growth and metastasis [170] (Fig. 2B).